Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | ACP3 | P15309 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | ADRB2 | P07550 | 2/20 | 0.37 |
| ▸ | ADRB1 | P08588 | 2/20 | 0.37 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | IDO1 | P14902 | 1/20 | 0.36 |
| ▸ | TDO2 | P48775 | 1/20 | 0.36 |
| ▸ | IDO2 | Q6ZQW0 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | CXCL8 | P10145 | 1/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
| ▸ | CES1 | P23141 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14710510 | 0.80 | ALDH1A1 (0.48) | CASP1TSHRALDH1A1ACP3CYP3A4 | |
| SCHEMBL19451976 | 0.80 | ALDH1A1 (0.48) | CASP1TSHRALDH1A1ACP3CYP3A4 | |
| SCHEMBL607431 | 0.80 | HTT (0.41) | TSHRALDH1A1CYP3A4IDO1TDO2 | |
| SCHEMBL9724510 | 0.79 | CASP1 (0.41) | CASP1TSHRALDH1A1ACP3CYP3A4 | |
| SCHEMBL19451943 | 0.77 | TSHR (0.48) | CASP1TSHRALDH1A1ACP3CYP3A4 | |
| SCHEMBL8867146 | 0.77 | TSHR (0.48) | CASP1TSHRALDH1A1ACP3CYP3A4 | |
| SCHEMBL8069967 | 0.77 | TSHR (0.48) | CASP1TSHRALDH1A1ACP3CYP3A4 | |
| SCHEMBL29973372 | 0.77 | TSHR (0.48) | CASP1TSHRALDH1A1ACP3CYP3A4 | |
| SCHEMBL29845650 | 0.77 | TSHR (0.48) | CASP1TSHRALDH1A1ACP3CYP3A4 | |
| SCHEMBL8934234 | 0.76 | CASP1 (0.42) | CASP1TSHRALDH1A1ACP3CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2084164-A2 | IMPROVED PROCESS FOR PREPARING CLOPIDOGREL | Teva Pharmaceutical Industries Ltd. (IL) | 2009-08-05 | — | — | EP | claimed |
| US-20080287679-A1 | Process for preparing clopidogrel | TEVA PHARMACEUTICALS USA, INC. | 2008-11-20 | — | — | US | claimed |
| WO-2008130642-A2 | IMPROVED PROCESS FOR PREPARING CLOPIDOGREL | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2008-10-30 | — | — | WO | claimed |
| CN-106167483-B | It can be used for compound, composition and the method for cholesterol mobilization | 塞伦尼斯医疗控股有限公司 | 2019-02-15 | — | — | CN | disclosed |
| CN-106167483-A | Can be used for compound, compositions and method that cholesterol is mobilized | 塞伦尼斯医疗控股有限公司 | 2016-11-30 | — | — | CN | disclosed |
| CN-103442714-A | Compounds, compositions and methods useful for cholesterol mobilization | CERENIS THERAPEUTICS HOLDING SA | 2013-12-11 | — | — | CN | disclosed |
| EP-2084164-A2 | IMPROVED PROCESS FOR PREPARING CLOPIDOGREL | Teva Pharmaceutical Industries Ltd. (IL) | 2009-08-05 | — | — | EP | disclosed |
| US-20080287679-A1 | Process for preparing clopidogrel | TEVA PHARMACEUTICALS USA, INC. | 2008-11-20 | — | — | US | disclosed |
| WO-2008130642-A2 | IMPROVED PROCESS FOR PREPARING CLOPIDOGREL | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2008-10-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080287679-A1 | Process for preparing clopidogrel | P2RY6, P2RY12, P2RY11 | CASP1 3808/4885TSHR 2205/4885ALDH1A1 611/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.